BioTeke-Manufactured Saliva Pregnancy Test Obtains ANVISA Registration in Brazil

BioTeke announces that a saliva-based pregnancy test manufactured by the company has obtained ANVISA registration in Brazil. The registration marks a new regulatory milestone for BioTeke’s saliva-based pregnancy testing technology.

The product uses saliva rather than urine, offering a different sampling approach within the pregnancy self-testing category. This development brings together BioTeke’s focus on saliva-based diagnostics and the work required to address individual market requirements.

A Saliva-Based Approach to Pregnancy Self-Testing

BioTeke’s Saliva Pregnancy Test Kit is designed for the qualitative detection of human chorionic gonadotropin (hCG) in saliva. As a pregnancy self-test, it provides an alternative sample type to conventional urine-based tests.

For IVD importers, distributors and pharmacy groups evaluating pregnancy testing portfolios, the sample type is an important product distinction. Assessment should also consider the intended use, supporting evidence, instructions for use and requirements of the target market.

The saliva-based format should be evaluated on its own documented characteristics. A different sample type does not, by itself, establish superior accuracy or faster results compared with urine-based testing.

A Regulatory Milestone in Brazil

ANVISA registration in Brazil represents an important milestone for the specific saliva-based pregnancy test manufactured by BioTeke.

For BioTeke, the achievement is part of the broader process of developing its international IVD business while addressing the requirements of each market. The announcement concerns the registered product in Brazil and should not be interpreted as registration of every BioTeke product or version.

Market evaluation elsewhere remains a separate process. Product documentation, labeling and the applicable local requirements should be reviewed for each intended market.

Information for IVD Professionals

BioTeke welcomes product-related enquiries from IVD importers, distributors and pharmacy groups interested in understanding saliva-based pregnancy testing.

Professional enquiries may cover the product’s intended use, sampling approach, supporting documentation and market-specific evaluation needs. Discussing these points early can help establish a clear basis for further technical and commercial assessment.

To learn more about the Saliva Pregnancy Test Kit, contact BioTeke with your company details, target market and information requirements.